Neostigmine Methylsulfate 76045-0214-30

Package NDC

76045-0214-30

Manufacturer: Fresenius Kabi Usa, Llc
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: September 18, 2018
Listing Expires: December 31, 2026
Application: NDA203629

Need to source Neostigmine Methylsulfate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Neostigmine Methylsulfate	1 mg/mL

Drug Class

Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]

Selected Package

76045-0214-30Selected

10 BLISTER PACK in 1 CARTON (76045-214-30) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-214-00) / 3 mL in 1 SYRINGE, GLASS